| FOLFOX Regimen studied in …STUDIED_INderived163 of 163show fewer |
|---|
| → studied in | NCT05482893Phase 1/Phase 2 · recruiting Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) · 163 trials list this drug (53 active) | — | — | Malignant Biliary Tract Neoplasm,Malignant Colorectal Neoplasm,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05712356Phase 2 · completed A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors · 163 trials list this drug (53 active) | — | — | Intrahepatic Cholangiocarcinoma,Malignant Bile Duct Neoplasm,Malignant Gallbladder Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06663319Phase 1 · recruiting A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers · 163 trials list this drug (53 active) | — | — | Digestive System Neoplasm,Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07221357Phase 2/Phase 3 · recruiting A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07284849Phase 3 · recruiting A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04929223Phase 1 · recruiting A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC) · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625775Phase 1 · recruiting Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors · 163 trials list this drug (53 active) | — | — | Adult Solid Neoplasm,Malignant Breast Neoplasm,Malignant Lung Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07221149Phase 2/Phase 3 · recruiting A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204) · 163 trials list this drug (53 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06529718Phase 2 · recruiting Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients · 163 trials list this drug (53 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07603375Phase 2 · not yet recruiting Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma · 163 trials list this drug (53 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04068610Phase 1/Phase 2 · active not recruiting COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC · 163 trials list this drug (53 active) | — | — | Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05024097Phase 2 · recruiting A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer. · 163 trials list this drug (53 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05476796Phase 2 · active not recruiting Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer · 163 trials list this drug (53 active) | — | — | Esophageal Adenocarcinoma,Gastric Adenocarcinoma,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05836324Phase 1 · recruiting A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors · 163 trials list this drug (53 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06719362Phase 1 · recruiting A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies · 163 trials list this drug (53 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06179160Phase 1 · recruiting A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation · 163 trials list this drug (53 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07340567Phase 3 · active not recruiting Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood Test · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02009449Phase 1 · completed A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors · 163 trials list this drug (53 active) | — | — | Solid Neoplasm,Malignant Breast Neoplasm,Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05864105Phase 2 · completed PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma · 163 trials list this drug (53 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06509880Phase 2/Phase 3 · completed Immunosurveillance for Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07655024Phase 2 · recruiting TAIC FOLFOX for Locally Advanced G/GEJA · 163 trials list this drug (53 active) | — | — | Malignant Gastric Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06106308Phase 2 · active not recruiting Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation · 163 trials list this drug (53 active) | — | — | Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07318389early Phase 1 · not yet recruiting ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06783491Phase 3 · recruiting Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Colon Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03781323Phase 2 · active not recruiting Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07622017Phase 2 · not yet recruiting KORTUC (KRC-01) Plus Radiotherapy for Organ Preservation in Rectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06598007Phase 1/Phase 2 · recruiting A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors · 163 trials list this drug (53 active) | — | — | Adult Solid Neoplasm,Malignant Colorectal Neoplasm,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03548961Phase 2 · active not recruiting Organ Preservation in Early Rectal Cancer Patients · 163 trials list this drug (53 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05702229Phase 2 · recruiting Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma · 163 trials list this drug (53 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00959647Phase 2 · completed A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study · 163 trials list this drug (53 active) | — | — | Basal Cell Carcinoma,Malignant Ovarian Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03904043NA · completed Non-Operative Management and Early Response Assessment in Rectal Cancer · 163 trials list this drug (53 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07562490Phase 2 · recruiting A Randomized Controlled Trial of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy Decision-Making in High-Risk Stage III (T4N+ or T1-3N2) Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07562711Phase 2 · recruiting Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06846346Phase 2 · recruiting Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma · 163 trials list this drug (53 active) | — | — | Esophageal Adenocarcinoma,Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06475352Phase 2 · recruiting Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07522411Phase 1/Phase 2 · not yet recruiting Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma · 163 trials list this drug (53 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05108428early Phase 1 · active not recruiting Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma · 163 trials list this drug (53 active) | — | — | Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02359968Phase 2 · completed PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer · 163 trials list this drug (53 active) | — | — | Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04808323Phase 1 · recruiting MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer · 163 trials list this drug (53 active) | — | — | Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07472868Phase 3 · not yet recruiting Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer · 163 trials list this drug (53 active) | — | — | Rectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03516708Phase 1/Phase 2 · recruiting Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07323576Phase 2 · withdrawn A Study to Evaluate the Efficacy and Safety of Inavolisib When Administered in Combination With Bevacizumab and FOLFOX or FOLFIRI as First Line Therapy in Participants With Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00208260Phase 2/Phase 3 · completed Intensified Chemotherapy in CRC After Resection of Liver Metastases · 163 trials list this drug (53 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07389265Phase 3 · recruiting Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05855200Phase 3 · recruiting Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer · 163 trials list this drug (53 active) | — | — | Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07353827Phase 2 · not yet recruiting FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma · 163 trials list this drug (53 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05171166Phase 2/Phase 3 · terminated Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial. · 163 trials list this drug (53 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06154538Phase 2 · recruiting Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05033522Phase 2/Phase 3 · suspended Immunotherapy for Advanced Liver Cancer · 163 trials list this drug (53 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07204574Phase 1/Phase 2 · recruiting The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04595266Phase 2 · active not recruiting Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease · 163 trials list this drug (53 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07192185Phase 2 · recruiting Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & Bevacizumab · 163 trials list this drug (53 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06253611Phase 2 · recruiting First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer · 163 trials list this drug (53 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04919226Phase 3 · active not recruiting Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE · 163 trials list this drug (53 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05480306Phase 2 · completed Phase 2 Study of DKN-01 in Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Colorectal Adenocarcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07074353Phase 3 · not yet recruiting Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03186326Phase 2 · completed Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00873275Phase 1 · completed Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06991465Phase 2 · recruiting Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA) · 163 trials list this drug (53 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05312398Phase 2 · active not recruiting CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen · 163 trials list this drug (53 active) | — | — | Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03861702Phase 2 · completed Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma: · 163 trials list this drug (53 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06919848Phase 2 · not yet recruiting Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06) · 163 trials list this drug (53 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860477Phase 2 · recruiting Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01) · 163 trials list this drug (53 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03597581Phase 1 · completed A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Digestive System Neoplasm,Gastric Neoplasm,Malignant Digestive System Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06293625Phase 3 · recruiting Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced but Resecable Colon Cancer in the Elderly of 70 Years Old or More · 163 trials list this drug (53 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00059930Phase 1 · completed Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04380337Phase 2 · completed Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03117972Phase 2 · terminated Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03662659Phase 2 · completed An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers · 163 trials list this drug (53 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01167725Phase 3 · terminated Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03635021Phase 3 · active not recruiting Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01274962Phase 2 · completed A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal Cancer · 163 trials list this drug (53 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01515787Phase 2/Phase 3 · unknown PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06123455Phase 2 · unknown Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer · 163 trials list this drug (53 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00958737Phase 3 · unknown Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06003998Phase 2 · unknown Intraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab · 163 trials list this drug (53 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00994864NA · completed Preoperative Chemosensitivity Testing to Predict Treatment Benefit in Adjuvant Stage III Colon Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05718492NA · recruiting A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents · 163 trials list this drug (53 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00851136Phase 1 · completed A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g) · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03883802Phase 2 · unknown Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00364013Phase 3 · completed PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05535647Phase 2 · unknown Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma · 163 trials list this drug (53 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02839343Phase 2 · unknown Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer · 163 trials list this drug (53 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03254394Phase 1/Phase 2 · completed Lidocaine for Oxaliplatin-induced Neuropathy · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04991948Phase 1 · recruiting Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00591123Phase 2 · completed Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia · 163 trials list this drug (53 active) | — | — | Esophageal Adenocarcinoma,Gastric Cardia Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381706Phase 2 · completed Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer · 163 trials list this drug (53 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070213Phase 3 · completed Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02934464Phase 3 · unknown Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers · 163 trials list this drug (53 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01276379Phase 2 · completed Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02845908Phase 2 · completed POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC · 163 trials list this drug (53 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066274Phase 2 · completed Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006050Phase 2 · completed Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver · 163 trials list this drug (53 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03760614Phase 1 · withdrawn A Study of Entinostat and FOLFOX in Subjects With Pancreatic Adenocarcinoma · 163 trials list this drug (53 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03164382Phase 3 · completed Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma · 163 trials list this drug (53 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03692429Phase 1 · recruiting alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00265811Phase 3 · completed Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04621370Phase 2 · unknown A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer · 163 trials list this drug (53 active) | — | — | Rectal Neoplasm,Malignant Rectal Neoplasm,Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02923921Phase 3 · completed Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer · 163 trials list this drug (53 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04167007Phase 3 · unknown FOLFOX vs Gemcitabine in Patients With Metastatic Pancreatic Cancer Non-fit to FOLFIRINOX · 163 trials list this drug (53 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03035253Phase 1 · terminated A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03982121Phase 1 · withdrawn Study of Intratumoral Ipilimumab and TLR4 Agonist GLA-SE in Combination With Systemic Nivolumab and Chemotherapy · 163 trials list this drug (53 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01498289Phase 2 · completed S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer · 163 trials list this drug (53 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01248299Phase 2 · terminated Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer. · 163 trials list this drug (53 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02002195unknown Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric Cancer · 163 trials list this drug (53 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02486601Phase 2 · unknown NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma · 163 trials list this drug (53 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01283204Phase 2 · completed Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer · 163 trials list this drug (53 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01632306Phase 1/Phase 2 · terminated A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer · 163 trials list this drug (53 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00613080Phase 2 · completed Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00551213Phase 2 · completed A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003) · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03469479Phase 3 · unknown Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria · 163 trials list this drug (53 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00832299Phase 2 · terminated Neo-Adjuvant FOLFOX for Rectal Carcinoma · 163 trials list this drug (53 active) | — | — | Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03377842Phase 2 · unknown Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00463840Phase 1/Phase 2 · terminated Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer · 163 trials list this drug (53 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03362684Phase 3 · completed PETACC-8 miR-31-3p and miR-31-5p Ancillary Study · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387387Phase 1 · completed Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin) · 163 trials list this drug (53 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03280407Phase 2 · unknown NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer · 163 trials list this drug (53 active) | — | — | Intestinal Neoplasm,Colorectal Neoplasm,Malignant Colorectal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01418222Phase 2 · completed FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01047293Phase 1/Phase 2 · completed RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01270438Phase 2 · withdrawn Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Colon Adenocarcinoma,Malignant Colon Neoplasm,Malignant Rectal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00399035Phase 3 · completed Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352755Phase 2 · terminated A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis · 163 trials list this drug (53 active) | — | — | Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01611857Phase 1/Phase 2 · completed Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach · 163 trials list this drug (53 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00873756Phase 1 · completed A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01269229Phase 2 · completed A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis · 163 trials list this drug (53 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02590367Phase 2/Phase 3 · unknown Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy · 163 trials list this drug (53 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01030042Phase 3 · completed Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic Patients · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890305Phase 2 · completed Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00778830Phase 1/Phase 2 · completed Study Evaluating the Safety and Efficacy of FOLFIRI Plus Cetuximab or FOLFOX Plus Cetuximab as First-line Therapy in Subjects With KRAS Wild-type Metastatic Colorectal Cancer (APEC-Study) · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00673673Phase 2 · completed FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer · 163 trials list this drug (53 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00646607Phase 3 · completed FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01748851Phase 3 · terminated XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC) · 163 trials list this drug (53 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004206Phase 2 · unknown Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer · 163 trials list this drug (53 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02128425Phase 2 · unknown FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00494221Phase 1/Phase 2 · completed A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008281Phase 3 · unknown Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008060Phase 3 · completed Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016198Phase 2 · completed Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039611NA · completed Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00103298Phase 2 · completed Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025142Phase 2 · completed Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00615056Phase 2 · completed A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen · 163 trials list this drug (53 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00202787Phase 2 · completed Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004127Phase 2 · completed Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach · 163 trials list this drug (53 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016978Phase 2 · completed Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008294Phase 1 · completed Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00043004Phase 2 · terminated Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00349336Phase 3 · completed A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101894Phase 1 · completed Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003287Phase 3 · completed Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00286130Phase 2 · completed Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00786006Phase 2 · completed Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer · 163 trials list this drug (53 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866944Phase 2 · completed Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases · 163 trials list this drug (53 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00502567Phase 1 · completed A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors · 163 trials list this drug (53 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006479Phase 3 · unknown Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004102Phase 2 · completed Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00160030Phase 2 · completed Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer · 163 trials list this drug (53 active) | — | — | Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00884767Phase 2 · unknown Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00478946Phase 1/Phase 2 · unknown A Study of Picoplatin in Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003260Phase 3 · unknown Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006115Phase 2 · unknown Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006468Phase 3 · unknown Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00116506Phase 2 · completed Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer · 163 trials list this drug (53 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |